A Registry of Patients With Primary Indeterminate Lesions or Choroidal Melanoma

Status: Recruiting
Location: See all (15) locations...
Study Type: Observational
SUMMARY

The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness of AU-011 and standard of care therapy. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: No
View:

• Have been clinically diagnosed with primary IL or CM at the time of entry to a previous Aura Biosciences sponsored clinical trial.

• Have received AU-011 or assigned to an observation cohort in a previous Aura sponsored clinical trial.

Locations
United States
Arizona
Retina Associates SW, P.C.
Recruiting
Tucson
California
UCLA Jules Stein Eye Institute
Recruiting
Los Angeles
Byers Eye Institute at Stanford University
Recruiting
Palo Alto
Retina Consultants of Sacramento
Recruiting
Sacramento
Massachusetts
Massachusetts Eye and Ear Infirmary
Recruiting
Boston
Michigan
W. K. Kellogg Eye Center, University of Michigan
Recruiting
Ann Arbor
Associated Retinal Consultants, PC
Recruiting
Royal Oak
Minnesota
Retina Center
Recruiting
Minneapolis
New York
Columbia University Medical Center
Recruiting
New York
Oregon
Oregon Health & Science University Casey Eye Institute
Recruiting
Portland
Pennsylvania
Wills Eye Hospital
Recruiting
Philadelphia
South Carolina
Retina Consultants of Carolina, PA
Recruiting
Greenville
Tennessee
St. Thomas Health / Tennessee Retina, PC
Recruiting
Nashville
Texas
Texas Retina Associates
Recruiting
Dallas
Retina Consultants of Houston
Recruiting
Houston
Contact Information
Primary
Medical Monitor
clinical@aurabiosciences.com
617-500-8864
Backup
Medical Monitor
Time Frame
Start Date: March 27, 2019
Estimated Completion Date: December 2029
Participants
Target number of participants: 500
Treatments
Patients previously participated in an Aura Biosciences study
Patients with Choroidal Melanoma or Indeterminate Lesions.
Related Therapeutic Areas
Sponsors
Leads: Aura Biosciences

This content was sourced from clinicaltrials.gov

Similar Clinical Trials